Literature DB >> 26508469

Increased risk of brain tumor in patients with Parkinson's disease: a nationwide cohort study in Taiwan.

C-F Tang1,2, M-K Lu1,2,3, C-H Muo2,4, C-H Tsai1,2,3, C-H Kao5,6.   

Abstract

OBJECTIVES: Parkinson's disease (PD) is a neurodegenerative disease. A decreased risk of cancer, except for melanoma, has been observed in patients with PD. The aim of this study was to evaluate the association between brain tumor and PD in a Taiwanese population.
MATERIALS AND METHODS: We used data from the National Health Insurance program of Taiwan. The PD cohort contained 2998 patients, and each patient was frequency-matched, based on age and sex, with 4 people without PD, who were randomly selected from the general population. Cox's proportional hazard regression analysis was conducted to estimate the effects of PD on the risk of brain tumor.
RESULTS: The risk of developing brain tumor was significantly higher in patients with PD than in those without PD (adjusted hazard ratio = 2.11; 95% confidence interval (CI) = 1.24-3.59), and benign brain tumor exhibited a particularly elevated risk of 2.16-fold (95% CI = 1.26-3.68). The hazard ratio (HR) for developing a benign brain tumor was higher in female patients with PD than in female patients without PD, with the risk being 2.65-fold (95% CI = 1.30-5.43). An analysis of the two age groups, 50-64 years and ≥65 years, showed that the HR of only the 50-64-year group was significantly higher between the PD and non-PD groups (HR = 2.77, 95% CI = 1.07-7.14).
CONCLUSION: The present study showed that Taiwanese patients with PD are at a higher risk of developing brain tumor than the general population. The exact underlying etiologies require further investigation.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  National Health Insurance (NHI) program; Parkinson's disease; brain tumor

Mesh:

Year:  2015        PMID: 26508469     DOI: 10.1111/ane.12524

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  5 in total

1.  The Relationship between Parkinson Disease and Brain Tumor: A Meta-Analysis.

Authors:  Rong Ye; Ting Shen; Yasi Jiang; Lingjia Xu; Xiaoli Si; Baorong Zhang
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

Review 2.  Biological and Clinical Implications of Comorbidities in Parkinson's Disease.

Authors:  Jose A Santiago; Virginie Bottero; Judith A Potashkin
Journal:  Front Aging Neurosci       Date:  2017-12-04       Impact factor: 5.750

3.  Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of observational studies.

Authors:  Ferrán Catalá-López; Brian Hutton; Jane A Driver; Matthew J Page; Manuel Ridao; José M Valderas; Adolfo Alonso-Arroyo; Jaume Forés-Martos; Salvador Martínez; Ricard Gènova-Maleras; Diego Macías-Saint-Gerons; Benedicto Crespo-Facorro; Eduard Vieta; Alfonso Valencia; Rafael Tabarés-Seisdedos
Journal:  Syst Rev       Date:  2017-04-04

4.  Parkinson's disease and cancer: a systematic review and meta-analysis on the influence of lifestyle habits, genetic variants, and gender.

Authors:  Joon Yan Selene Lee; Jing Han Ng; Seyed Ehsan Saffari; Eng-King Tan
Journal:  Aging (Albany NY)       Date:  2022-03-05       Impact factor: 5.682

5.  Parkinson's disease and cancer: a systematic review and meta-analysis of over 17 million participants.

Authors:  Xinyuan Zhang; David Guarin; Niyaz Mohammadzadehhonarvar; Xiqun Chen; Xiang Gao
Journal:  BMJ Open       Date:  2021-07-02       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.